LOS ALTOS, Calif., April 3, 2019 /PRNewswire-PRWeb/ -- UberCloud, a provider of cloud-based engineering simulation
Reducing the Cost and Risk of Drug Trials
Before new drugs reach the market, pharmaceutical companies must determine whether the drug might induce arrhythmias, a potentially lethal side effect. Traditionally this process is completed with extensive human and animal testing, which not only is costly and time-intensive, but also presents ethical concerns.
The Stanford Living Heart Project partnered with UberCloud, HPE, Dassault Systèmes, and Advania to develop a new software tool that enables drug developers to quickly assess whether a new drug compound causes arrhythmias, offering a means for getting safer drugs to market much faster, and with less reliance on human and animal testing.
The experiment has already received wide recognition. UberCloud CEO Burak Yenier was awarded best paper at the Intel HPC Developer Conference for his presentation of the project. Meanwhile, the Stanford Living Heart Project team received the HPCWire Editor's Choice Award for Best Use of HPC in the Cloud. And the HPC User Forum Steering Committee gave the project its Hyperion Award for Innovation Excellence.
Powering Affordable, Non-invasive Treatment Options
Conventional treatments for schizophrenia include psychotropic drugs, which come with multiple troublesome side effects, or deep brain stimulation (DBS), which has historically required highly invasive and risky surgery to place electrodes deep in a patient's brain. Each patient requires unique electrode placement.
The National Institute of Mental Health and Neuro-Sciences (NIMHANS) recently implemented UberCloud technology to explore the use of computer simulations for transcranial Direct Brain Stimulation (tDBS). A non-invasive treatment approach, tDBS holds great promise for the treatment of schizophrenia, along with other neuropsychiatric disorders like Parkinson's disease and depression. Using HPC-powered simulations, doctors can determine the individual electrode configurations required for each patient while the patient waits, and administer treatment in a much safer, more affordable outpatient setting.
The NIMHANS team closely collaborated with partners from UberCloud, Dassault Systèmes, SIMULIA, Advania Systems, Hewlett Packard Enterprise, and Intel. Their work won the 2018 Hyperion HPC Innovation Excellence Award, a distinction that recognizes the outstanding application of HPC technology for business and scientific achievements.
Download UberCloud's Compendium of ground breaking Life Sciences case studies here.
To learn more about how High Performance Computing (HPC) in the Cloud can help you with your CAE Simulations, schedule a Free Consultation with UberCloud's Experts.
About UberCloud UberCloud's mission is to make high performance computing (HPC) a reality for every engineer. UberCloud's HPC software containers enable companies of all sizes to quickly adopt the cloud for a high performance cloud computing solution, making it easy for engineers to access and use the cloud so they can benefit from HPC without any of the shortcomings. Visit UberCloud on the web, https://www.theubercloud.com, follow on Linkedin and Twitter.
Subscribe to our Free Newsletters!